Notably, CHD patients presented with higher levels of various biomarkers, such as age, troponin, BNP, D-dimer level (DD), neutrophil count (NEU#), neutrophil-to-lymphocyte ratio (NLR), myoglobin, and creatinine kinase-MB (CK-MB), and lower diastolic blood pressure, lymphocyte count (LYM#), and lymphocyte percentage (LYM%) (Table 2). The gene discussed is NPPB; the disease is coronary artery disorder.